Gut Microbe Diversity, Weight Linked

A genetic mapping study of intestinal bacteria shows that people with fewer and less diverse bacteria are at greater risk of obesity and associated diseases.

Written byChris Palmer
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, MATTOSAURUS

Individuals with fewer numbers of so-called “good” bacteria are more likely to be obese and develop obesity-related ailments such as type 2 diabetes, high cholesterol, and heart disease. That’s according to research conducted by the international MetaHIT consortium published Thursday (August 29) in Nature.

The MetaHIT team analyzed the genomes of gut bacteria from 123 non-obese and 169 obese Danish individuals. The resulting quantitative metagenomic analysis revealed stark differences between people with high versus low bacterial diversity. Individuals with more diversity had an average of 580,000 different microbial genes, compared to just 380,000 among the nearly 25 percent of the cohort with reduced diversity. Obesity was more prevalent in the reduced diversity population, as was increased resistance to insulin and higher levels of inflammatory agents ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies